Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 1073-1084, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linder, M. W.
Right arrow Articles by Keck, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linder, M. W.
Right arrow Articles by Keck, P. E., Jr.
Related Collections
Right arrow National Academy of Clinical Biochemistry
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 1998;44:1073-1084.)
© 1998 American Association for Clinical Chemistry, Inc.

NACB Symposium

Standards of laboratory practice: antidepressant drug monitoring

Mark W. Linder1,a, and Paul E. Keck, Jr.2

1 Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY 40292.

2 Biological Psychiatry Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45221.
a Author for correspondence. Fax 502-852-8299; e-mail mwlind01{at}homer.louisville.edu.

Therapeutic drug monitoring (TDM) for certain tricyclic antidepressants (TCAs) and lithium is supported on the basis of clearly defined therapeutic ranges. TDM is of particular importance in individuals whose pharmacokinetic behavior may differ from that of the general population or is changing as the result of aging and maturation. Once steady-state drug concentrations are achieved, serum or plasma specimens should be collected during the terminal drug-elimination phase and separated from cellular blood components immediately. Methods of analysis must be specific for parent drug and active metabolites and demonstrate imprecision (CVs) within 5–10% over the therapeutic range. For support of overdose situations, semiquantitative values for TCAs and quantitative measures of lithium should be available within 1 h, and routine TDM results should be reported within 24 h of receipt in the laboratory. Standardized and rigorous laboratory practices contribute to improved therapeutic management.




The following articles in journals at HighWire Press have cited this article:


Home page
 J. Clin. Pathol.Home page
W S A Smellie, J Forth, S Ryder, M J Galloway, A C Wood, and I D Watson
Best practice in primary care pathology: review 5
J. Clin. Pathol., December 1, 2006; 59(12): 1229 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. Leboulanger, J.-M. Aubry, G. Bondolfi, R. H. Guy, and M. B. Delgado-Charro
Lithium Monitoring by Reverse Iontophoresis in Vivo
Clin. Chem., November 1, 2004; 50(11): 2091 - 2100.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
W. Steimer, K. Zopf, S. von Amelunxen, H. Pfeiffer, J. Bachofer, J. Popp, B. Messner, W. Kissling, and S. Leucht
Allele-Specific Change of Concentration and Functional Gene Dose for the Prediction of Steady-State Serum Concentrations of Amitriptyline and Nortriptyline in CYP2C19 and CYP2D6 Extensive and Intermediate Metabolizers
Clin. Chem., September 1, 2004; 50(9): 1623 - 1633.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Martinavarro-Dominguez, M.-E. Capella-Peiro, M. Gil-Agusti, J. V. Marcos-Tomas, and J. Esteve-Romero
Therapeutic Drug Monitoring of Anticonvulsant Drugs by Micellar HPLC with Direct Injection of Serum Samples
Clin. Chem., October 1, 2002; 48(10): 1696 - 1702.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.